PUBLISHER: The Business Research Company | PRODUCT CODE: 1947093
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947093
A robotic surgical companion refers to an advanced robotic system that assists surgeons during surgical procedures by offering precision, improved dexterity, and real-time guidance, which enhances surgical outcomes and minimizes procedural risks. It also simplifies complex surgical tasks, enabling minimally invasive techniques and promoting faster patient recovery.
The main components of robotic surgical companions include hardware, software, and services. Hardware consists of the physical components that form the robotic system, encompassing product types such as surgical robots, robotic surgical assistants, robotic navigation systems, and others. These systems are utilized in various applications, including general surgery, urology, gynecology, orthopedics, cardiovascular surgery, neurosurgery, and others, and are employed by end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.
Tariffs have increased costs of robotic arms, precision sensors, control systems, and imaging components used in robotic surgical companions. The impact is strongest in hardware-intensive surgical robots manufactured in Asia-Pacific and deployed in North America and Europe. Although tariffs have raised capital costs and slowed adoption, they have also promoted domestic manufacturing, modular system design, and strategic partnerships to improve cost efficiency.
The robotic surgical companion market research report is one of a series of new reports from The Business Research Company that provides robotic surgical companion market statistics, including robotic surgical companion industry global market size, regional shares, competitors with a robotic surgical companion market share, detailed robotic surgical companion market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgical companion industry. This robotic surgical companion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The robotic surgical companion market size has grown rapidly in recent years. It will grow from $6.9 billion in 2025 to $7.86 billion in 2026 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to shortage of skilled surgeons, rising surgical complexity, demand for minimally invasive procedures, technological advances in robotics, hospital investment in advanced surgery.
The robotic surgical companion market size is expected to see rapid growth in the next few years. It will grow to $13.07 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to AI-enabled surgical assistance, expansion of robotic surgery training, growing outpatient surgeries, demand for faster patient recovery, integration with imaging systems. Major trends in the forecast period include precision-assisted surgical procedures, minimally invasive robotic surgery, surgeon guidance and decision support, enhanced surgical dexterity systems, operating room workflow optimization.
The increasing incidence of cancer is expected to drive the growth of the robotic surgical companion market in the coming years. Cancer is a disease characterized by the uncontrolled multiplication of abnormal cells that can invade nearby tissues and spread to other parts of the body. The rise in cancer cases is largely attributed to unhealthy lifestyle habits such as poor diet, lack of physical activity, and tobacco use, which heighten the risk of cell damage and abnormal growth. Robotic surgical companions play a crucial role in cancer treatment by enabling highly precise and minimally invasive procedures that minimize damage to healthy tissues and support faster recovery. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that the number of new cancer cases is projected to surpass 35 million by 2050, representing a 77% increase compared to approximately 20 million cases in 2022. Therefore, the growing prevalence of cancer is contributing to the expansion of the robotic surgical companion market.
Leading companies in the robotic surgical companion market are emphasizing technological advancements, particularly in AI-powered robotic surgery systems, to enhance surgical precision, reduce operating time, and improve patient outcomes. An AI-powered robotic surgery system combines artificial intelligence algorithms with robotic instruments to assist surgeons in planning, guiding, and executing procedures with greater accuracy and efficiency. For example, in July 2025, CARE Hospitals, an India-based healthcare provider, introduced the Stryker Mako Robotic System to improve precision in orthopedic surgeries. This advanced AI-based technology enables highly accurate and personalized joint replacement surgeries using detailed 3D modeling and real-time robotic assistance. Its key advantages include enhanced surgical accuracy, reduced tissue trauma, less postoperative pain, faster recovery, and more predictable outcomes. The system aims to improve the quality and consistency of orthopedic surgeries, supporting better long-term joint function with shorter hospital stays and fewer complications compared to conventional techniques.
In October 2025, Zimmer Biomet Holdings Inc., a US-based medical device company, acquired Monogram Technologies Inc. for an undisclosed amount. This acquisition aims to strengthen Zimmer Biomet's leadership in orthopedic surgery innovation by incorporating Monogram's AI-driven technologies to create the first fully autonomous robotic surgical solutions. The move expands Zimmer Biomet's robotics portfolio and provides surgeons with a more comprehensive and advanced robotic ecosystem to improve surgical outcomes. Monogram Technologies Inc. is a US-based medical device company specializing in robotic surgical companions.
Major companies operating in the robotic surgical companion market are Intuitive Surgical Inc., Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Asensus Surgical Inc., Globus Medical Inc., Distalmotion SA, Medicaroid Corporation, CMR Surgical Ltd., Johnson & Johnson, Smith & Nephew plc, eCential Robotics SAS, Renishaw plc, Meere Company Inc., avateramedical GmbH, Robocath SAS, Preceyes B.V., Neocis Inc., Microbot Medical Inc., NDR Medical Technology Pte. Ltd., Accuray Incorporated
North America was the largest region in the robotic surgical companion market in 2025. The regions covered in the robotic surgical companion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the robotic surgical companion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The robotic surgical companion market consists of revenues earned by entities providing services such as robotic-assisted surgery, surgical planning and navigation support, real-time intraoperative guidance, system maintenance and software updates, and training and simulation for surgeons. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic surgical companion market also includes sales of robotic instrument holders, robotic endoscopic systems, and haptic feedback devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Robotic Surgical Companion Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses robotic surgical companion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for robotic surgical companion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robotic surgical companion market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.